Status:
COMPLETED
EXIBIT: Oxaliplatin in Biliary Tract Cancer
Lead Sponsor:
Sanofi
Conditions:
Biliary Tract Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary objective is to evaluate the efficacy of the GEMOX treatment as 1st line therapy in patients with advanced biliary tract cancer based on response rate measured by the RECIST unidimensional...
Eligibility Criteria
Inclusion
- Histologically proven, locally advanced or metastatic carcinoma of the biliary tract (gallbladder, intrahepatic bile ducts, extrahepatic bile ducts, ampula of Vater)
- For intrahepatic bile ducts, if the diagnosis of biliary tract origin is not evident by imaging or surgical exploration, and so equivalent to liver metastasis with unknown primary site, inclusion is possible if:
- unknown primary after an exhaustive search for the primary site (chest radiography- , thoracic and abdomino pelvic CT scan, colonoscopy, oesogastroduodenal endoscopy, PSA determination for men or mammography for women, and PET scan if possible).
- histological examination compatible with adenocarcinoma of bile ducts with the immunostaining expression of cytokeratin : 7+, 20- and 19 +. (Shimonishi, 2000 \^22)
- No prior chemotherapy for advanced disease (first line)
- No radiation therapy within 4 weeks prior to the first gemcitabine administration.
- Unidimensionally measurable disease.
- For female patient of childbearing potential, neither pregnant nor breastfeeding, and under active contraception
- No known allergy to one of the study drugs
- No prior malignancy
- No CNS metastases
- No peripheral neuropathy \> grade 2
- ECOG PS \<=2
- ANC \> 1.5 X 10\^9 /L
- Platelets \> 100 X 10\^9 /L
- Creatinine \< 1.5 x ULN
- SGPT (ALT) \< 5 x ULN
- Bilirubin \< 2.5 x ULN (patients with jaundice or evidence of bile duct obstruction and in whom the biliary tree can be decompressed by endoscopic percutaneous endoprothesis, with subsequent reduction in bilirubin \< 2.5 x ULN will be eligible for the study).
Exclusion
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT00174564
Start Date
April 1 2003
End Date
September 1 2006
Last Update
February 17 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.